Michael Patrick Miller insider trades

Open-market stock purchases and sales by Michael Patrick Miller, Director at Puma Biotechnology, Inc, from SEC Form 4 filings since Apr 30, 2010.

Recent trades

DateStockTradeValue
Jun 11, 2026PBYI Puma Biotechnology, IncBought (not open market)—
May 15, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Feb 1, 2026RIGL Rigel Pharmaceuticals IncBought (not open market)—
Jan 9, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Nov 11, 2025PBYI Puma Biotechnology, IncSold$97.2K

Companies traded

  • PBYI Puma Biotechnology, Inc: 6 sales, last Jun 11, 2026
  • RIGL Rigel Pharmaceuticals Inc: other filings, last May 15, 2026
  • BTAI BioXcel Therapeutics, Inc: other filings, last Jan 9, 2026
  • JAZZ Jazz Pharmaceuticals plc: 40 sales, last Mar 12, 2020
  • VVUS Vivus Inc: 3 sales, last Jan 25, 2013

Get free alerts when Michael Patrick Miller files a new trade →